National Science Foundation
- Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19): In light of the emergence and spread of the coronavirus disease 2019 (COVID-19) in the United States and abroad, the National Science Foundation (NSF) is accepting proposals to conduct non-medical, non-clinical-care research that can be used immediately to explore how to model and understand the spread of COVID-19, to inform and educate about the science of virus transmission and prevention, and to encourage the development of processes and actions to address this global challenge.
- Dear Colleague Letter: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19) The Office of Advanced Cyberinfrastructure (OAC) within the Directorate for Computer and Information Science and Engineering is inviting RAPID proposals and supplemental funding requests to existing awards that address COVID-19 challenges through data and/or software infrastructure development activities. Such activities would be funded by the Computational and Data-Enabled Science and Engineering (CDS&E) program or the Cyberinfrastructure for Sustained Scientific Innovation (CSSI) program. Proposals in response to this DCL and the NSF DCL on COVID-19 (NSF 20-052) may also request the use of NSF-funded advanced computing resources such as Frontera, Stampede2, Bridges, Comet, and JetStream. To ensure availability of these computing resources, investigators must contact OAC prior to submission of the proposal.
- NSF SBIR/STTR Phase I Proposals Addressing COVID-19: The Division of Innovation and Industrial Partnerships (IIP) of the Engineering Directorate invites US-based small businesses to submit Phase I proposals focused on the development and deployment of new technologies, products, processes, and services with the potential to positively impact the nation’s and world’s ability to respond to the COVID-19 crisis. Areas of research that might be considered include, but are not limited to: artificial intelligence, digital health, diagnostics, distributed ledger, environmental technologies, medical devices, pharmaceutical technologies, disinfection and sterilization, and filtration and separations. Interested proposers are invited to submit to the NSF Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Phase I Program.
National Institutes of Health
- Notice of Special Interest (NOSI): Urgent Competitive Revisions to Accelerate Research on the Development of Predictive Models of the Spread of SARS-CoV-2 and Outcomes of Potential Public Health Interventions on COVID-19 Notice Number: NOT-GM-20-027
- Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) Related to HIV Comorbidities, Coinfections, and Complications within NIDDK's Mission Notice Number: NOT-DK-20-020
- Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities Notice Number: NOT-MD-20-019
- Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences Notice Number: NOT-OD-20-097
- Notice of Special Interest (NOSI): National Cancer Institute Announcement Regarding Availability of Urgent Competitive Revision and Administrative Supplements on Coronavirus Disease 2019 (COVID-19) Notice Number: NOT-CA-20-042
- Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional) FOA Number PA-20-135
- Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement – Clinical Trial Optional) FOA Number PA-18-935
- Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIDDK Notice Number: NOT-DK-20-018
- NIEHS Worker Training Program Coronavirus and Infectious Disease Response Training (Admin Supp Clinical Trial Not Allowed) Notice Number: NOT-ES-20-017
- Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus Notice Number: NOT-TR-20-016
- Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required) FOA Number PAR-20-139
- Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV) NOT-AI-20-030: IAID and NIGMS are issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on the 2019 novel Coronavirus (2019-nCoV). NIAID is particularly interested in projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeutics against 2019-nCoV.
- Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) NOT-HL-20-757 NHLBI is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on Coronavirus Disease 2019 (COVID-19) and on biological effects of its causative agent, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Topics of specific interest to NHLBI include host response, associations with heart, lung, and blood (HLB) diseases, potential impacts on transfusion safety, and clinical outcomes of infected individuals.
- Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus NOT-DA-20-047 NIDA is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on the 2019 Novel Coronavirus (2019-nCoV, also known as COVID-19). NIDA is especially interested in research collecting and examining data on the risks and outcomes for COVID-19 infection in individuals suffering from substance use disorders.
- Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) Notice Number: NOT-TR-20-012
- Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need Notice Number: NOT-TR-20-011
- Notice of Special Interest (NOSI): Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) Notice Number: NOT-EB-20-007
- Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) Notice Number: NOT-DC-20-004
Department of Defense
- Prototype Development to Combat Novel Coronavirus Disease COVID-19: In light of the magnitude and potential threat that the coronavirus (COVID-19) poses to our military’s health and readiness, the Government seeks to rapidly accelerate the inquiry, testing, and fielding of new 21st century capabilities, employing novel technologies and approaches to the detection of exposure, prevention, containment and treatment of COVID-19 and future emerging threats.
- DOD’s Project Vulcan released a DIY Hack-a-Vent Innovation Challenge With the current COVID-19 (Coronavirus) pandemic, the US and world face a realistic threat of overwhelming the medical system, and more specifically, running out of available ventilators. With SARS-CoV-2 viruses (to include the Coronavirus), the primary area of the body impacted is the pulmonary system. In certain individuals, Acute Respiratory Distress Syndrome (ARDS) develops and rapidly leads to a critical need for mechanical ventilation/breathing support. We are entering a time period, however, where “ventilators are like gold,” and we anticipate a potential for a widespread lack of ventilators to support critical care requirements across the nation and the world. Due to the epidemiology of the disease, time is of the essence. Over the next 2-weeks, this Innovation Challenge seeks to pool the brilliant minds and expertise of our Nation to develop a low-cost, non-FDA approved, mechanical ventilation support system that can be rapidly produced at local levels with widely available resources.
- Medical Technology Enterprise Consortium (MTEC) MTEC is issuing this announcement announcement for a Request for Project Proposals (RPP) focused on the development of prototypes aimed to treat COVID-19 with the following focus area: Therapeutic(s) that can treat COVID-19. Treatments with potential application to the prevention of COVID-19 infection are desired. Therapeutics that can be administered in a non-hospital environment are desired. Enhanced White Papers are due no later than April 8, 2020 at 12:00 pm Eastern Time. Due to the critical and urgent nature of the technical topic area, MTEC membership is NOT required for the submission of an Enhanced White Paper in response to this MTEC RPP. However, membership will be required for Offerors recommended for award.
- MTEC anticipates releasing several COVID-19 RPPS. Pre-Announcements are posted here: https://www.mtec-sc.org/upcoming-solicitations/ Once they are open RPPS are posted here with all the details: (due dates/format/submission info etc.) https://www.mtec-sc.org/solicitations/
- Active: 20-09-COVID-19 Development of Treatments for COVID-19 Amendment 1
- Pre-Announcement Released: 20-10-COVID-19_NETCCN Telehealth patient management to monitor and direct care to non-hospital settings
- Potential Upcoming: Treatment of COVID-19 related Severe Acute Respiratory Distress Syndrome and Acute Lung Injury Technologies to reduce medical workforce burden and maximize resource utilization
Point-of-care diagnostics to rapidly ID infected individuals
Predictive analytics that can forecast potential hot spots and empower decision makers response actions
Centers for Disease Control and Prevention
- Strengthening Public Health Systems and Services Through National Partnerships to Improve and Protect the Nation’s Health
Department of Energy
- The Gates Foundation, American Heart Association (AHA), Russell Sage Foundation, etc.